Reorganization of Substance Use Treatment and Harm Reduction Services during the COVID-19 Pandemic: A Global Survey
Access Status
Authors
Date
2020Type
Metadata
Show full item recordCitation
Source Title
Collection
Abstract
Background: The COVID-19 pandemic has impacted people with substance use disorders (SUDs) worldwide and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health response is categorized around (1) managerial measures and systems, (2) logistics, (3) service providers and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and, 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. 57% of overdose prevention interventions and 81% of outreach services also having been negatively impacted. Conclusions: Participants reported that SUD treatment and harm reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we provide a series of recommendations to support countries to be prepared more efficiently for future waves or similar pandemics to 1) help policymakers generate business continuity plans, 2) maintain use of evidence-based interventions for people with SUDs, 3) be prepared for adequate medication supplies, 4) integrate harm reduction programs with other treatment modalities and 5) have specific considerations for vulnerable groups such as immigrants and refugees. Highlights: COVID-19 negatively impacted services for PWSUD globally. Addiction medicine downgraded more than other psychiatry services. Business continuity plan for PWSUD services reported only in about half of the countries. Refugees & migrants had more negative impact compared to other vulnerable groups. Harm reduction services discontinued partially or totally during pandemic.
Related items
Showing items related by title, author, creator and subject.
-
Radfar, S.R.; De Jong, C.A.J.; Farhoudian, A.; Ebrahimi, M.; Rafei, P.; Vahidi, M.; Yunesian, M.; Kouimtsidis, C.; Arunogiri, S.; Massah, O.; Deylamizadeh, A.; Brady, K.T.; Busse, A.; ISAM-PPIG Global Survey Consortium; Potenza, M.N.; Ekhtiari, H.; Baldacchino, A.M.; Myers-Franchi, Bronwyn (2021)Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: ...
-
Roxburgh, A.; Livingston, Michael ; Dietze, P.; Nielsen, S.; Cogger, S.; Bartlett, M.; Day, C.; Latimer, J.; Jauncey, M.; Clark, N. (2023)Objectives: The COVID-19 pandemic disrupted service provision of harm reduction and drug treatment services for people who inject drugs in many countries. The two supervised injecting facilities (SIFs) in Sydney and ...
-
Harker, N.; Johnson, K.; Erasmus, J.; Myers-Franchi, Bronwyn (2022)Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide. The aim of this study was to explore, changes in the number of SUD treatment episodes provided ...